Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Versus Surveillance After Radical Prostatectomy in High Grade Prostate Cancer
NCT00376792Phase 3Unknown
- Sponsor
- Scandinavian Prostate Cancer Group
- Start
- Oct 2005
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by Scandinavian Prostate Cancer Group. Status: unknown.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00376792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376792.